Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

November 17, 2017

Study Completion Date

December 17, 2017

Conditions
Glioma (Diagnosis)
Interventions
DEVICE

Tc-99M-Tetrofosmin SPECT

DEVICE

F-18 FDG PET

Trial Locations (9)

Unknown

Service de Neurologie Mazarin Hôpital Pitié-Salpêtrière, Paris

Országos Klinikai Idegtudományi Intézet (OKITI), Budapest

Országos Onkológiai Intézet, Budapest

Pozitron-Diagnosztika Ltd., Budapest

Scanomed Budapest, Budapest

Uzsoki Utcai Kórház, Budapest

Debreceni Egyetem Orvos- és Egészségtudományi Centrum, Debrecen

Scanomed Debrecen, Debrecen

Pécsi Tudományegyetem, Általános, Pécs

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

ConsulTech GmbH

UNKNOWN

collaborator

pharmtrace

UNKNOWN

collaborator

Pharmathen S.A.

INDUSTRY

lead

Proactina S.A.

OTHER

NCT02971319 - Technical Performance Assessment of Tc-99m Tetrofosmin for Differentiation of Recurrence vs Radiation Necrosis in Patients With Glioma | Biotech Hunter | Biotech Hunter